Organophosphate pesticide exposures, nitric oxide synthase gene variants, and gene–pesticide interactions in a case–control study of parkinson’s disease, California (USA)

Environmental Health Perspectives

Volumn 124, Issue 5, 2016, Pages 570-577

  Paul, Kimberly C ^a   Sinsheimer, Janet S ^a,b   Rhodes, Shannon L ^a   Cockburn, Myles ^c   Bronstein, Jeff ^b   Ritz, Beate ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; NITRIC OXIDE SYNTHASE; ORGANOPHOSPHATE PESTICIDE; ARYLDIALKYLPHOSPHATASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, HUMAN; ORGANOPHOSPHORUS COMPOUND; PESTICIDE; POLLUTANT;

ADULT; ARTICLE; ARYLDIALKYLPHOSPHATASE 1 GENE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; GEOGRAPHIC INFORMATION SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; NITRIC OXIDE SYNTHASE GENE; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; CALIFORNIA; ENVIRONMENTAL EXPOSURE; GENETICS; POLLUTANT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TOXICITY;

ARYLDIALKYLPHOSPHATASE; CALIFORNIA; CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HUMANS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; ORGANOPHOSPHORUS COMPOUNDS; PARKINSON DISEASE; PESTICIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84964851327     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1408976     Document Type: Article

References (44)

1. Bagchi D, Bagchi M, Hassoun EA, Stohs SJ. 1995. In vitro and in vivo generation of reactive oxygen species, DNA damage and lactate dehydroge-nase leakage by selected pesticides. Toxicology 104:129-140, doi:10.1016/0300-483X(95)03156-A.
2. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265, doi:10.1093/bioinformatics/bth457.
3. CDPR (California Department of Pesticide Regulation). 2013a. Pesticide Use Reporting (PUR). Available: http://www.cdpr.ca.gov/docs/pur/purmain.htm [accessed 28 July 2015].
4. CDPR. 2013b. California Product/Label Database Queries & Lists. Available: http://www.cdpr.ca.gov/ docs/label/labelque.htm [accessed 28 July 2015]. CDWR (California Department of Water Resources). 2013.
5. Land Use Surveys. Available: http://www. water.ca.gov/landwateruse/lusrvymain.cfm [accessed 28 July 2015].
6. Cockburn M, Mills P, Zhang X, Zadnick J, Goldberg D, Ritz B. 2011. Prostate cancer and ambient pesti-cide exposure in agriculturally intensive areas in California. Am J Epidemiol 173:1280-1288; doi:10.1093/aje/kwr003.
7. Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B. 2009. Parkinson’s disease and residential exposure to maneb and paraquat from agricultural applications in the Central Valley of California. Am J Epidemiol 169:919-926, doi:10.1093/aje/kwp006.
8. Dauer W, Przedborski S. 2003. Parkinson’s disease: mechanisms and models. Neuron 39:889-909, doi:10.1016/S0896-6273(03)00568-3.
9. Gauderman WJ, Morrison J. 2006. QUANTO 1.2: a Computer Program for Power and Sample Size Calculations for Genetic-Epidemiology Studies. Available: http://biostats.usc.edu/cgi-bin/ DownloadQuanto.pl [accessed 17 March 2016].
10. Hague S, Peuralinna T, Eerola J, Hellström O, Tienari PJ, Singleton AB. 2004. Confirmation of the protective effect of iNOS in an independent cohort of Parkinson disease. Neurology 62:635-636, doi:10.1212/01.WNL.0000110191.38152.29.
11. Hancock DB, Martin ER, Vance JM, Scott WK. 2008. Nitric oxide synthase genes and their inter-actions with environmental factors in Parkinson’s disease. Neurogenetics 9:249-262, doi:10.1007/s10048-008-0137-1.
12. Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, Matthews RT, et al. 1996. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 2:1017-1021, doi:10.1038/nm0996-1017.
13. Huerta C, Sánchez-Ferrero E, Coto E, Blázquez M, Ribacoba R, Guisasola LM, et al. 2007. No asso-ciation between Parkinson’s disease and three polymorphisms in the eNOS, nNOS, and iNOS genes. Neurosci Lett 413:202-205, doi:10.1016/j.neulet.2006.11.044.
14. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. 1992. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopatho-logic study. Neurology 42:1142-1146, doi:10.1212/WNL.42.6.1142.
15. Hunot S, Boissière F, Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, et al. 1996. Nitric oxide synthase and neuronal vulnerability in Parkinson’s disease. Neuroscience 72:355-363, doi:10.1016/0306-4522(95)00578-1.
16. Ioannidis JPA. 2007. Non-replication and inconsis-tency in the genome-wide association setting. Hum Hered 64:203-213, doi:10.1159/000103512.
17. Jacob EL, Gatto NM, Thompson A, Bordelon Y, Ritz B. 2010. Occurrence of depression and anxiety prior to Parkinson’s disease. Parkinsonism Relat Disord 16:576-581, doi:10.1016/j.parkreldis.2010.06.014.
18. Kang GA, Bronstein JM, Masterman DL, Redelings M, Crum JA, Ritz B. 2005. Clinical characteristics in early Parkinson’s disease in a central California population-based study. Mov Disord 20:1133-1142, doi:10.1002/mds.20513.
19. Kavya R, Saluja R, Singh S, Dikshit M. 2006. Nitric oxide synthase regulation and diversity: impli-cations in Parkinson’s disease. Nitric Oxide 15:280-294, doi:10.1016/j.niox.2006.07.003.
20. Kegley SE, Hill BR, Orme S, Choi AH. 2014. PAN Pesticide Database, Pesticide Action Network, North America (Oakland, CA, 2014). Available: http://pesticideinfo.org/ [accessed 17 March 2016].
21. Langston JW. 1985. MPTP and Parkinson’s disease. Trends Neurosci 8:79-83, doi:10.1016/0166-2236(85)90031-1.
22. Lee PC, Rhodes SL, Sinsheimer JS, Bronstein J, Ritz B. 2013. Functional paraoxonase 1 variants modify the risk of Parkinson’s disease due to organophos-phate exposure. Environ Int 56:42-47, doi:10.1016/j.envint.2013.03.004.
23. Levecque C, Elbaz A, Clavel J, Richard F, Vidal JS, Amouyel P, et al. 2003. Association between Parkinson’s disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study. Hum Mol Genet 12:79-86, doi:10.1093/hmg/ddg009.
24. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, et al. 1999. Inducible nitric oxide synthase stimulates dopa-minergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5:1403-1409, doi:10.1038/70978.
25. Licinio J, Prolo P, McCann SM, Wong ML. 1999. Brain iNOS: current understanding and clinical impli-cations. Mol Med Today 5:225-232, doi:10.1016/S1357-4310(99)01453-7.
26. Liew Z, Wang A, Bronstein J, Ritz B. 2014. Job exposure matrix (JEM)-derived estimates of lifetime occupational pesticide exposure and the risk of Parkinson’s disease. Arch Environ Occup Health 69:241-251, doi:10.1080/19338244.2013.778808.
27. Lukaszewicz-Hussain A. 2010. Role of oxidative stress in organophosphate insecticide toxicity—short review. Pestic Biochem Physiol 98:145-150, doi:10.1016/j.pestbp.2010.07.006.
28. Meara J, Bhowmick BK, Hobson P. 1999. Accuracy of diagnosis in patients with presumed Parkinson’s disease. Age Ageing 28:99-102, doi:10.1093/ageing/28.2.99.
29. Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, et al. 2014. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet 46:989-993, doi:10.1038/ng.3043.
30. Narayan S, Liew Z, Paul K, Lee PC, Sinsheimer JS, Bronstein JM, et al. 2013. Household organophos-phorus pesticide use and Parkinson’s disease. Int J Epidemiol 42:1476-1485, doi:10.1093/ije/dyt170.
31. NCI-NHGRI Working Group (NCI-NHGRI Working Group on Replication in Association Studies), Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, et al. 2007. Replicating genotype- phenotype associations. Nature 447:655-660, doi:10.1038/447655a.
32. O’Leary KA, Edwards RJ, Town MM, Boobis AR. 2005. Genetic and other sources of variation in the activity of serum paraoxonase/diazoxonase in humans: consequences for risk from exposure to diazinon. Pharmacogenet Genomics 15:51-60, doi:10.1097/01213011-200501000-00008.
33. Ott J. 2004. Association of genetic loci: replication or not, that is the question. Neurology 63:955-958, doi:10.1212/WNL.63.6.955.
34. Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM. 1996. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced dopami-nergic neurotoxicity. Proc Natl Acad Sci USA 93:4565-4571, doi:10.1073/pnas.93.10.4565.
35. Ritz B, Rhodes SL, Bordelon Y, Bronstein J. 2012. α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease. PLoS One 7:e36199, doi:10.1371/journal.pone.0036199.
36. Ryan SD, Dolatabadi N, Chan SF, Zhang X, Akhtar MW, Parker J, et al. 2013. Isogenic human iPSC Parkinson’s model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription Cell 155:1351-1364, doi:10.1016/j.cell.2013.11.009.
37. Schapira AHV. 2006. Etiology of Parkinson’s disease. Neurology 66(10 suppl 4):S10-S23, doi:10.1212/WNL.66.10_suppl_4.S10.
38. Schiesling C, Kieper N, Seidel K, Krüger R. 2008. Review: familial Parkinson’s disease—genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease. Neuropathol Appl Neurobiol 34:255-271, doi:10.1111/j.1365-2990.2008.00952.x.
39. Schulte C, Sharma M, Mueller JC, Lichtner P, Prestel J, Berg D, et al. 2006. Comprehensive association analysis of the NOS2A gene with Parkinson disease. Neurology 67:2080-2082, doi:10.1212/01.wnl.0000247672.41736.bd.
40. Schulz JB, Matthews RT, Muqit MM, Browne SE, Beal MF. 1995. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 64:936-939.
41. Tobler AR, Short S, Andersen MR, Paner TM, Briggs JC, Lambert SM, et al. 2005. The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping. J Biomol Tech 16:398-406.
42. Varçin M, Bentea E, Michotte Y, Sarre S. 2012. Oxidative stress in genetic mouse models of Parkinson’s disease. Oxid Med Cell Longev 2012:624925, doi:10.1155/2012/624925.
43. Wang A, Costello S, Cockburn M, Zhang X, Bronstein J, Ritz B. 2011. Parkinson’s disease risk from ambient exposure to pesticides. Eur J Epidemiol 26:547-555, doi:10.1007/s10654-011-9574-5.
44. Wermuth L, Lassen CF, Himmerslev L, Olsen J, Ritz B. 2012. Validation of hospital register-based diag-nosis of Parkinson’s disease. Dan Med J 59:A4391.